We’ve heard some of the shortcomings of pharma logistics, but what happens when things go wrong?

What can be done to improve logistics? And which mode of transport should companies choose?

“Brexit and Trump” were the talk of Dublin town at the 2018 Biopharma Ambition conference.

Health Technology Assessments are a way of life for the pharma industry, but are all HTAs equal?

Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions.

Pharma calls for close cooperation and clarity as soon as possible.

An implantable neural device can deliver drugs to the brain with pinpoint accuracy.

Brexit could cause chaos for fragile supply chains – especially if companies are unprepared.

A half-century-old “bet hedging” hypothesis explains the effectiveness of many drug combinations.

Some patients, particularly children, find medicines unpalatable – and genetics could be the cause.